178 filings
8-K
ABBV
AbbVie Inc.
19 Feb 25
Other Events
9:22am
8-K
ABBV
AbbVie Inc.
14 Feb 25
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
7:30am
8-K
ABBV
AbbVie Inc.
5 Feb 25
Other Events
4:15pm
8-K
ABBV
AbbVie Inc.
31 Jan 25
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
7:42am
8-K
ABBV
AbbVie Inc.
10 Jan 25
Material Impairments
8:31am
8-K
r0dgfc6kudbcxxs313nf
6 Jan 25
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:02pm
8-K
wookp3
13 Dec 24
Departure of Directors or Certain Officers
4:05pm
8-K
6uw r7qbv
30 Oct 24
AbbVie Reports Third-Quarter 2024 Financial Results
7:43am
8-K
t384jwfhgsj
3 Oct 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:07pm
8-K
b4x zvb5a97xl4qr
10 Sep 24
Amendments to Articles of Incorporation or Bylaws
3:30pm
8-K
0zquh innky53u7zpo
25 Jul 24
AbbVie Reports Second-Quarter 2024 Financial Results
7:41am
8-K
7awdbm
3 Jul 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
2:07pm
8-K/A
8mx7zh7t7d41
8 May 24
Departure of Directors or Certain Officers
5:00pm
8-K
yzicwqqmwpj2 ivxc8s5
26 Apr 24
AbbVie Reports First-Quarter 2024 Financial Results
7:43am
8-K
u01bvkgp727qeihhw1s
3 Apr 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:06pm
8-K
wqloge 7qbdr3rz3y5s
26 Feb 24
Other Events
5:08pm
8-K
ecu w0ywr
20 Feb 24
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
9:00am
8-K
kme snhv30afvk5z
12 Feb 24
AbbVie Completes Acquisition of ImmunoGen
7:49am
8-K
zr7e7qdzb6cui3
2 Feb 24
AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results
7:51am
8-K
kqgyl2p9
5 Jan 24
Guidance Including the Impact of Acquired IPR&D and Milestones Expense
4:03pm